about
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signalingMain roads to melanomaNovel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesionsTwo types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapyThe role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesisTherapeutic Implications of Targeting AKT Signaling in MelanomaTranscriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicityInvolvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanomaA phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaMechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cellsSesterterpenoids with Anticancer ActivityThe pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapyMelanoma: from mutations to medicineContinuing to illuminate the mechanisms underlying UV-mediated melanomagenesisSynthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidinsOrphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathwayTargeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanoma.Prognostic Impact of Autophagy Biomarkers for Cutaneous MelanomaRoles of Erythroid Differentiation Regulator 1 (Erdr1) on Inflammatory Skin DiseasesQuercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development StrategyRhoJ regulates melanoma chemoresistance by suppressing pathways that sense DNA damageAugmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistanceSynergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanomaAnti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cellsImatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1Proteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cellsApoptosis induced by Ginkgo biloba (EGb761) in melanoma cells is Mcl-1-dependentApoptosis related protein-1 triggers melanoma cell death via interaction with the juxtamembrane region of p75 neurotrophin receptorA melanoma molecular disease modelEvaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma modelsSystems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells.Methylation-controlled J-protein MCJ acts in the import of proteins into human mitochondria.The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells.Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik.Suppression subtractive hybridization profiles of radial growth phase and metastatic melanoma cell lines reveal novel potential targets.Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species.Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
P2860
Q21133611-B943B3DC-B235-41AB-9CE9-B39BAA6EFBEBQ21245465-38BB6BB2-BB76-495D-ADB0-9B139A4A80C4Q24318456-FDAF67BC-4072-4112-97CE-4DFE419963F8Q24598856-5CDD03E3-EDF6-45F6-A0BC-305FCE091E6AQ24626306-3E1D83E4-526B-4C21-90BC-A8A2361159F4Q24631438-EF3F8FEA-9688-4652-82CE-52231D6502EDQ24633850-21E13F6A-0623-4D30-A1FD-435FEE4AEFA3Q24649754-DE210350-4527-4CFA-A69B-E698D3539CFFQ24658533-A9D0EF9B-36D7-4A2D-9534-031884F1C693Q24810540-39F1C3DF-B93E-4181-9E89-60988E04B9A7Q26795736-3D9F6980-4A2D-462B-8953-87D2EF13D640Q27004672-C814147F-1D2A-485E-B3CC-CE27D28877AFQ27024061-EC10D949-CD6A-4272-B870-4E09783FC0A1Q27026261-3B84E2A0-F9F1-41D7-AE83-B80ECFA18D61Q27336331-DD27D590-3B64-42CC-AF02-5A727C3D9B67Q27687897-933BB336-2765-40C1-8427-63BEC25C6975Q27853026-2E5C381B-EE62-4318-B305-012DEC598BC6Q28067140-B0F843A6-FFC2-4956-8AD2-885C75084F83Q28074548-C68B0677-C7A8-4AF5-85AA-4769A334CEB3Q28076840-DA5E2668-402B-48D6-8BF5-34611CCCB2BFQ28274939-93AF07C7-9F42-4251-A784-A89ABF6D677BQ28276508-B87945C3-2C38-4286-A131-56B5F60D8C04Q28277703-F195315B-1129-4067-9FBA-96F089355248Q28476828-C374A124-D19F-4A15-B600-E9CCDB385FE0Q28484515-7C5D858A-32E0-42A1-8B76-096C1CB12460Q28485861-E385D456-1F9A-46BE-ABC5-D9DC9EE34DFCQ28534817-9A159664-C4D5-4BAF-8E0C-4A33CB665166Q28649832-0C8BC935-249B-4DFD-AE2D-0C12A15F333DQ28661691-404A427B-51ED-4EB7-81DD-AA057158B91CQ28741507-3B5DE965-2A54-4794-9BF6-E1933A696961Q28817211-0CF4E968-337E-49B4-8F20-6142C37956DEQ30549646-068A4B50-8E7A-4A8C-8E42-8CC6AE40C517Q30668565-D1F5EE5E-78BC-4ED2-9366-58FFFFD30D17Q30837718-6BC59023-8576-42A3-B665-A307545E6AB5Q30940472-A21FAD4F-456A-4A70-AC40-D73AC75AF9EDQ33218584-DA866CF1-CD25-4848-9648-ED50861169D7Q33315713-1A36B052-D4CC-4305-8A34-D2C4E09B08B2Q33403800-72FF0670-6827-4C89-85FA-674C6B47D07FQ33448422-46FA505B-69D3-48F6-9791-62928EDD8D98Q33601945-C55349CA-5B17-4790-84F3-0405EF5BAEE5
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Apoptosis and melanoma chemoresistance.
@ast
Apoptosis and melanoma chemoresistance.
@en
type
label
Apoptosis and melanoma chemoresistance.
@ast
Apoptosis and melanoma chemoresistance.
@en
prefLabel
Apoptosis and melanoma chemoresistance.
@ast
Apoptosis and melanoma chemoresistance.
@en
P356
P1433
P1476
Apoptosis and melanoma chemoresistance.
@en
P2093
María S Soengas
Scott W Lowe
P2888
P304
P356
10.1038/SJ.ONC.1206454
P407
P577
2003-05-01T00:00:00Z
P5875
P6179
1051330539